Health
NIH launches clinical trial to test antibody treatment in hospitalized COVID-19 patients – EurekAlert
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized, controlled trial, known as ACTIV-3, and as a ”master pro…
IMAGE: Colorized scanning electron micrograph of a cell (purple) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in…
view more
Credit: NIAID
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized, controlled trial is known as ACTIV-3, and as…
-
Noosa News17 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News19 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General22 hours agoOne person dead after house fire in Melbourne’s south-east
-
Noosa News15 hours agoFranz Ferdinand: Australian Tour 2025